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CC BY-NC-ND license (http://creativeAbstract Infertility due to low testosterone levels has increased in recent years. This has
impacted the social well-being of the patients. This study was undertaken to investigate the po-
tential of gonadotropins in facilitating differentiation of human bonemarrowmesenchymal stem
cells (BMSCs) into Leydig cells in vitro. BMSCswere isolated, cultured, and their biological charac-
teristicswereobserved.BMSCswere inducedwithgonadotropins in vitroandtheir ability todiffer-
entiate into Leydig cells was studied. The level of expression of 3-beta hydroxysteroid
dehydrogenase (3b-HSD) and secretion of testosterone were determined using flow cytometry
and enzyme-linked immunosorbent assay, respectively, and the results were compared between
the experimental and control groups. The cultured BMSCs showed a typical morphology of the
fibroblast-like colony. The growth curve of cells formed an S-shape. After inducing the cells for
8e13days, thecells in theexperimental group increased in size andshowed typical characteristics
of Leydig cells, and the growth occurred in spindle or stellate shapes. Cells from the experimental
grouphighlyexpressed3b-HSD,andtherewasagradual increase in thenumberofLeydig cells. The
control group did not express 3b-HSD. The level of testosterone in the experimental group was
higher than the control group (p<0.05). Additionally, thecells in theexperimental group secreted
higher levels of testosterone with increased culture time. The expression of Leydig cell-specific
markers in the experimental group was significantly higher (p< 0.05). With these findings, BMSCs
can be considered a new approach for the treatment of patients with low androgen levels.
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In recent years, with the rising industrial and social devel-
opment, environmental pollution is also on the rise. A lot of
stressful conditions that young men face in their life, along
with indulging in bad habits, such as drinking, smoking, and
staying up late, have led to an increase in the number of
patients with infertility. Although the extent of infertility
varies considerably among countries, infertility has been
recognized as a public health issue worldwide by the World
Health Organization (WHO), and has the potential to
threaten the stability of individuals, relationships, and
communities [1]. Infertility has been associated in patients
with low testosterone levels, and has serious implications
on their mental and social well-being. It has become the
focus of research in the past decade, and is now considered
an andrological disease.
Transplantation of Leydig cells has become a main
treatment modality in patients with low testosterone levels
[2,3]. When transplanted, Leydig cells are involved in
regulating the secretion of androgens under the body’s
normal physiological laws [4]. However, this method is
limited by the nonavailability of cell sources, immune
rejection, and a relatively short duration of action [5,6],
and therefore, is not conducive to clinical applications.
The concept of mesenchymal stem cells (MSCs) was pro-
posed in 1968 by Friedenstein et al. [7], when they found
that MSCs are a kind of adult stem cells, derived from
autologous cells. MSCs display a high degree of proliferation,
self-renewal capacity, and a potential for multidirectional
differentiation of pluripotent stem cells [8,9], and the MSCs
in bone marrow mesenchymal stem cells (BMSCs) and fetal
cord blood show a greater level of these properties [10].
Also, there exists a difference in quality among the cell
sources of placenta, amniotic fluid, umbilical vein endo-
thelial layer, peripheral blood, liver, muscle, fat, skin, and
other tissues [11e13]. MSCs derived from early mesoderm
can assure neuroectodermal and endoderm differentiation
in exceptional conditions, with a variety of features added
to the cell differentiation potential [14]. Kale et al. [15]
reported that in a mouse model with acute renal failure,
transplanted MSCs could differentiate into renal tubular
epithelial cells, thus restoring the structure and function of
the kidneys. In their study, Wang et al. [16] observed that
BMSCs transplanted into the seminiferous tubules within the
seminiferous epithelium significantly restored the damaged
rat spermatogenic cells. If the direct differentiation of
BMSCs into Leydig cells can be induced, the issues of cell
origin and immune rejection can be addressed simulta-
neously. There are several advantages of using BMSCs, which
include: (1) their multi-directional differentiation poten-
tial; (2) their ease of acceptance and growth in the testis,
thereby overcoming the shortcomings of the immune
rejection in transplanted cells; (3) the important role they
play in improving the testicular environment, and in pro-
moting rapid recovery of androgen levels; and (4) the ease of
collecting BMSCs from autologous, allogeneic Leydig cells,
thus avoiding ethical issues of transplantation [17]. Ma¨kela¨
et al. [18] reported that various testicular cell growth mi-
croenvironments direct differentiation of BMSCs. Addition-
ally, they described BMSCs as cells with strong plasticity[18]. Transplantation of BMSCs through the multi-use in-
jection method may result in a large number of cells in
different positions and therefore, may not efficiently lead to
androgen production. Furthermore, the recipient animals
need more stringent requirements, thereby still leaving a
gap between research and clinical applications.
Leydig cells are distributed in the seminiferous tubules of
loose connective tissues, and account for 2e4% of the total
testicular cell number [19]. Leydig cells are themain source of
testosterone in males [20]. At present, several studies report
that BMSCs induce germ cell differentiation and in vivo
transplantation. Kale et al [15] transplanted BMSCs into the
testes of rats; the transplanted cells successfully survived and
differentiated into steroid hormone secreting Leydig cells.
Furthermore, MSCs were found to induce cAMP production
in vitro that in turn showed the ability to differentiate into
Leydig cells to produce testosterone. Lue et al. [3] injected
the BMSCs into the developmental stages of rat testis. After 2
weeks of culturing in vitro, these cells exhibited the charac-
teristics of Leydig cells and showed the ability to secrete
testosterone. In a previous study [21], we injected mouse
BMSCs labeled with Hoechest33342 into the testis. Interest-
ingly, the cells did not show immune rejection after trans-
plantation in the short term. In two separate studies, Ge et al.
[22,23] observed that the mature Leydig cells are terminal
cells, which do not have the ability to undergo mitosis.
Therefore, it becomes necessary for the stem Leydig cells
(SLC) and progenitor Leydig cells (PLC) to maintain the num-
ber of cells in the body. Such research confirms thatMSCs have
far-reaching applications in the male reproductive system.
In the present study, our aim was to isolate and culture
BMSCs in vitro; to use hormone-induced methods to cause
differentiation of Leydig cells; to study the testicular
growth in a microsimulation environment in order to pro-
mote the differentiation of BMSCs into Leydig cells; to
verify the pluripotent characteristics and plasticity of
BMSCs; and to discuss in vitro differentiation in drug-
induced conditions. An indepth research on these cells
and their differentiation phenomena will lay a foundation
for clinical applications in the future.
Methods
Source of bone marrow specimens
Volunteers were selected from among the medical in-
patients from the West China Hospital, Sichuan University,
Chengdu, China. Out of nine cases selected from January
2011 to October, 2011, five were males and four were fe-
males, with an average age of 37.2  9.4 years. These
patients were checked to rule out any disease history
before the onset of the new hematopoietic system disorder
or serious infectious disease. The bone marrow was trans-
planted through bone marrow puncture. At all times, the
volunteers signed informed consent accepted by the Ethics
Committee of West China Hospital of Sichuan University.
Isolation and culture of BMSCs
Density gradient centrifugation was used to obtain BMSCs.
Anticoagulated bone marrow fluid was centrifuged (200g for
Table 1 Primer sequences used for the amplification of
genes.
Gene Primer sequence (50-30)
b-Actin F-CAACCGTGAAAAGATGACCCAGATC
R-AGTCCATCACAATGCCTGTGGTAC
P450scc F-CCAGTGTCCCCATGCTCAAC
R-TGCATGGTCCTTCCAGGTCT
HSD3b1 F-TAACAATTTAACAGCCCCTCCTAAGG
R-ATCCAGCCATGGTCAACACA
HSD3b6 F-AAACCATCCTCCACTGTTCTAGCT
R-TGGAGATGGTCAGCCACAAG
The study of BMSCs into Leydig cells in vitro 35 min) and the upper fat (at 1:1, v:v) was slowly added to the
top of the Ficoll-Hypaque lymphocyte separation medium
(1.077 g/mL, Shanghai Reagent Factory, Shanghai, China),
and centrifuged at 400g for 30 minutes in order to collect the
intermediate mononuclear cells (MNCs). The cells were
washed twice with L-Dulbecco’s Modified Eagle’s Medium
(DMEM; Gibco, Carlsbad, CA, USA), centrifuged at 200g for 10
minutes, and subsequently inoculated at a density of
1  105 cells/cm2 in MesenCult of TM medium (Stem Cell
Technologies, Vancouver, BC, Canada) and 10% fetal bovine
serum (FBS, Baoxin Biological Technology, Chengdu, China).
The cells were cultured in a 5% CO2 incubator at saturated
humidity and 37C. The culture medium was changed for the
first time after 72 hours and henceforth, half themediumwas
changed twice a week. When these primary cultured cells
reached 80% confluence, the MSCs were harvested using TNE
(0.25% trypsin, 0.01% EDTA) digestion. The cells were then
passaged at a ratio of 1:2 to 1:3 to obtain the P1 culture; once
the cells reached close to 80% confluence, they were
passaged again to yield the P2 culture. The BMSCs were
seeded at a density of 1.0  104/mL in 96-well plates and
cultured for 1 day. Ten microliters of the cells were then
added to each well of the cell-counting kit (cck)-8, and the
light absorbance value was measured at 450 nm by enzyme-
linked immunosorbent assay (ELISA; Beckman Coulter, Full-
erton, CA, USA) continuously for 7 days. The results were
plotted with average incubation time on the horizontal axis
and the absorbance value on the vertical axis, thus depicting
a growth curve. MSCs at passage 3 (P3) were further induced
to produce Leydig cells.
In vitro induction of BMSCs into Leydig cells
The third-passage BMSCs were divided into two groups: (1)
the experimental group, cultured in conditional medium,
which was composed of different concentrations of human
menopausal gonadotropin/luteinizing hormone (HMG/LH;
West China Second Hospital of Sichuan University), 0.75 U/
mL of human chorionic gonadotropin (HCG; West China
Second Hospital of Sichuan University), 40 U/mL of
platelet-derived growth factor (PDGF, PeproTech, Rocky
Hill, USA), 10 ng/mL interleukin-1a (IL-1a; Pep Rotech), and
0.0005 ng/mL of FBS in DMEM medium; and (2) the control
group, which was cultured in fetal bovine serum (FBS) in
DMEM medium with normal sodium.
Testosterone analysis
The level of testosterone in the cell supernatant was
measured in the experimental group as well as the control
group by ELISA (Access Immunoassay System, Beckman, Cal-
ifornia, USA) at 7 day intervals (on Day 1, followed by Day 7,
Day 14, and Day 21). Results of induced testosterone pro-
duction in vitro were compared between the two groups
under study.
Immunofluorescence staining
The cells were fixed in acetone at 4C for 10 minutes. They
were then rinsed with PBS three times for 5 minutes, then
ruptured with 0.1% Triton-X-100 at room temperature for 10minutes, and again rinsed with PBS 3 times for 5 minutes
each. The anti-mouse anti-human monoclonal antibody, 3-
beta hydroxysteroid dehydrogenase (3b-HSD; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), was diluted (1:100)
with PBS, applied to the slides and incubated at 37C for 30
minutes. The slides were washed in PBS, placed on a shaker,
and dried naturally at room temperature. The goat anti-
mouse immunoglobulin IgG fluorescein isothiocyanate
(FITC)-conjugated antibody (green fluorescence; Beijing
Zhongshan Jinqiao Biological Technology, Beijing, China),
used as the secondary antibody, was diluted (1:50), then
applied over the cells and incubated at 4C for 1 hour. The
slides were later rinsed and dried. The results were observed
within 24 hours of staining under a fluorescence microscope.
Rabbit anti-immune serum was used as a negative control.
Features like cell integrity andmorphological structurewere
more evident using a bright field vision. Nuclei were stained
with 40,6-diamidino-2-phenylindole (DAPI; blue) under
confocal microscopy (IX81-type, Olympus Company, Tokyo,
Japan) and were regarded as positive cells. Cells seeded in
each group were randomly selected from five light micro-
scope field of view (100) and the number and proportion of
3b-HSD-stained cells were counted. The experiment was
repeated three times.
Flow cytometry
Cells of the experimental group and control group were har-
vested by treatment with 0.25% trypsin/EDTA at 7 day in-
tervals (Day 7, Day 14, Day 21, and Day 28), and were washed
with PBS 3 times. Cells were fixed using themethod described
in the earlier section. Subsequently, the primary antibody,
rat anti-human 3b-HSD monoclonal antibody (Santa Cruz
Biotechnology), and the secondary antibody, rabbit anti-
mouse second antibody (FITC Beijing Zhongshan Jinqiao Bio-
logical Technology, Beijing, China), were added to the cells.
FluorescenceActivatedCell Sorter (FACS)wasperformedona
flow cytometer (FCM, Beckman, California, USA) with a 480-
nm argon laser and the positive cells were isolated.
Semi-quantitative reverse transcription
polymerase chain reaction
Approximately 1  106 P3 cells were used for the extraction
of total cell RNA by Trizol extraction kit, according to
Figure 1. Morphology of the human bone marrow-derived, clonally expanded mesenchymal stem cells (MSCs) observed through
inverted phase contrast microscope. (A) At 20magnification, MSCs of fibroblast-like cells are fusiform afterw3e4 days, adherent,
contain monocytes, are refractive, and with a swirling arrangement. (B) At 40 magnification, 80e90% of cells showed fusion after
culture for 8e10 days. (C) At 100 magnification, red blood cells and other impurity cells gradually decreased after passage, cell
morphology gradually became uniform with fast growth; after 6e7 days the cells were passaged again.
Figure 2. The growth curve of human bone marrow mesen-
chymal stem cells (BMSCs) showing a rapid growth on Days 1e4,
with a gradual slowing down from Days 5e7. OD Z optical
density.
4 L. Hou et al.manufacturer’s instructions. The purity and concentration
of the RNA was measured using a UV spectrophotometer.
Through the use of a reverse transcription kit (Santa Cruz
Biotechnology), RNA was reverse transcribed into cDNA.
According to the reverse transcription polymerase chain
reaction (RT-PCR) kit, the amount of RNA used was 2 mL for
each of the reactions. The primer sequences used for the
amplification of P450scc, HSD3b1, HSD3b6, and HSD17b3
genes are presented in Table 1. The cycling conditions
employed were as follows: one cycle of denaturation at
95C for 2 minutes; followed by 30 cycles of 95C, 30
seconds (denaturation), 56C, 30 seconds (annealing), and
72C, 2 minutes (extension); and a final extension at 72C
for 6 minutes. Five microliters of the PCR products, mixed
with a buffer solution, were subjected to 2% agarose gel
electrophoresis. Ethidium bromide staining and UV illumi-
nation with a projector and camera were carried out, and
images were recorded and analyzed by an image analysis
system, obtaining P450scc, HSD3b1, mRNA, and HSD3b6
relative expression amounts. Results of the experimental
group were compared with the control group.
Statistical analysis
Data were analyzed through SPSS 16.0 software (SPSS Inc.,
Chicago, IL, USA). Data processing and measurement of
data applications were performed by the KruskaleWallis
test, while counting of data was performed through c2
test. A p value < 0.05 was considered statistically
significant.
Results
Human BMSCs: culturing and morphology
Human BMSCs were observed growing as adherent cells by
the inverted phase contrast microscope 24 hours after cellculture. The shape of the cells was round or oval, the
refractive index was found to be good, and some of the
adherent cells showed projections; the remaining non-
adherent cells were circular in shape, and were suspended
in the culture flask. MSCs of fibroblast-like cells were
fusiform after 3e4 days (Figure 1A, 20 magnification);
and it was a swirling arrangement. When mixed with a
small amount of red blood cells and other impurity cells,
80e90% of the cells showed fusion after culturing for 8e10
days (Figure 1B, 40 magnification). Red blood cells and
other impurity cells gradually decreased after further
passages, the cell morphology slowly became uniform, and
the cells began to grow fast. After 6e7 days, the cells
were passaged again (Figure 1C, 100 magnification) and
BMSC lines were successfully cultured. Using cck-8, the
absorbance was measured and the growth curve was
plotted, the result showed a rapid growth of BMSCs on
Days 1e4 (Figure 2). However, the growth slowed down
Figure 3. (A) Experimental group and (B) control group from
the third-passage bone marrow mesenchymal stem cells
(BMSCs), induced to differentiate into Leydig cells after 20
days of culture. (A) Image showing the cells connecting to each
other, and displaying reticular, spindle-shaped, and star-
shaped cells (100 magnification); and (B) third-generation
BMSCs of the control group (40 magnification).
The study of BMSCs into Leydig cells in vitro 5after 5 days, and no obvious proliferation was seen on
Days 6e7.In vitro induction of BMSCs into Leydig cells
Morphological changes of human BMSCs were induced by
the induction medium after 8e13 days. The cells connected
to each other, showed an adherent growth pattern and a
typical pull; were reticular, spindle-shaped, and star-
shaped; the nuclei were round and the visible morpholog-
ical features were characteristic to that of Leydig cells.
Hence, it could be deduced that the BMSCs had successfullyFigure 4. A confocal image showing positive expression of 3-b
mesenchymal stem cells (BMSCs) that differentiated into Leydig
differentiated cells of 3b-HSD positively expressed on Day 21 [g
secondary antibodies; green]; (B) nuclei were stained with 40,6-diam
HSD with DAPI.been transformed into Leydig cells (Figure 3A, 100
magnification).
Immunofluorescence staining
The cells in the experimental group were induced for
increasing periods of time and yielded a high-concentration
of 3b-HSD positive cells (Figures 4C and 5). The results
showed that the human BMSCs had differentiated into
Leydig cells.
FACS analysis
The rate of positive expression of 3b-HSD in cells, observed
through flow cytometry analysis, were 18.2%, 37.9%, 65.8%,
24.6% after 7 days, 14 days, 21 days, and 28 days of culture,
respectively; by contrast, the control group showed nega-
tive results (Figure 6AeE). During the induction of the
experimental group, expression of 3b-HSD in Leydig cells
was gradually found to increase, and reached a maximum
value after 21 days. However, after 28 days it started
showing a downward trend.
Detection of testosterone
The cells in the experimental group yielded higher levels of
testosterone in comparison to the control group; the high-
est value was obtained on the 21st day, and the level sta-
bilized by the 25th day. Additionally, the experimental
group showed an increase in testosterone level with an
increase in time, while the control group did not show any
significant change (Figure 7).
Semi-quantitative RT-PCR
The expression of P450scc, HSD3b1, and HSD3b6 in the cells
of the experimental group was observed to be higher thaneta hydroxysteroid dehydrogenase (3b-HSD) in bone marrow
cells after 20 days of culture (100 magnification). (A) The
oat anti-mouse immunoglobulin G-fluorescein isothiocyanate
idino-2-phenylindole (DAPI; blue); and (C) colocalization of 3b-
Figure 5. Human bone marrow mesenchymal stem cells
(BMSCs) with positive 3-beta hydroxysteroid dehydrogenase
(3b-HSD) obtained in immunofluorescence analysis. Differences
between the experimental and control groups were statisti-
cally significant (p < 0.05). 3b-HSD Z 3-beta hydroxysteroid
dehydrogenase.
6 L. Hou et al.in the control group (Figure 8) and these differences were
statistically significant at p < 0.05. The values corre-
sponding to the levels of expression of these genes are
presented in Table 2.Figure 6. Flow cytometric analysis of 3-beta hydroxysteroid dehy
(A) The result in the control group was negative. Rates of positive 3b
28 were 18.2%, 37.9%, 65.8%, and 24.6%. FITC Z fluorescein isothiDiscussion
In our previous experiments, we have confirmed that it is
difficult to obtain primary cells from cord blood MSCs [21].
Additionally, the impurities are difficult to remove in a
mixed cell culture, thus affecting the growth of the cells.
Furthermore, the cell culture period is longer, and the rate
of final harvest of cells is lower, making it difficult to
establish a complete cell culture system. However, the
content of BMSCs is higher than the cord blood, and is
relatively easy to obtain. In the present study, we used a
combination of Ficoll density gradient centrifugation and
adherence screening to isolate and screen BMSCs [24]. The
morphological properties and adherent patterns of growth
of BMSCs, after culturing for 24 hours, aided in their iden-
tification and removal of nonadherent cells. Using the cck-8
mapping growth curve, the activity and proliferation of
these cells were studied. We observed that the cells
exhibited adherent growth in colonies and colony forming
units-fibroblasts (CFU-Fs). BMSCs display typical biological
characteristics, viz. an ability to self-replicate; easy sepa-
ration, culture, and amplification; and maintenance of
multiple differentiation potential during the process of
long-term in vitro culture.
The culture medium, containing HCG, HMG [including
LH/follicle stimulating hormone (FSH)], PDGF, and IL-1a,
induced culturing of BMSCs. In the process of differentia-
tion and culture, Leydig cells are derived from precursordrogenase (3b-HSD) in the cells of the experimental group at P4.
-HSD expression on (B) Day 7, (C) Day14, (D) Day 21, and (E) Day
ocyanate.
Figure 7. Effect of induction fluid on testosterone produc-
tion by the cells in vitro, in the experimental and control
groups. Differences between the experimental and control
groups were statistically significant (p < 0.05).
Figure 8. Expression of P450scc, hydroxysteroid dehydro-
genase (HSD)3b1, and HSD3b6 in the cells of the experimental
group and the control group. HSD Z hydroxysteroid
dehydrogenase.
The study of BMSCs into Leydig cells in vitro 7cells, progenitor cells, newly formed adult Leydig cells,
immature adult Leydig cells, and mature Leydig cells or
adult Leydig cells [25]. In the hypothalamus, gonadotropin-
releasing hormone (GnRH) and corticotropin releasing hor-
mone (CRH) combine with the receptor from the pituitary
gland, thus resulting in the synthesis of LH and FSH. Mito-
chondrial cholesterol from cells leads to the formation of
pregnenolone, progesterone, androstenedione, and finally
testosterone. Sriraman et al. [26] reported that by blockingTable 2 Semiquantitative reverse transcription polymerase cha
Group
b-ACTIN P450sc
Experimental 1.511  0.212 1.261  0
Control 1.481  0.122 0.433  0
Differences between the experimental and control groups were statisLH in the rat testis, the number of Leydig cells and pro-
genitor cells decrease. FSH plays a role similar to Leydig
cell membrane receptors on the surface; thus by activating
adenylate cyclase, FSH generates the ring in adenosine
phosphate, which is in turn a substrate for phosphorylation
and has the same effect as LH. However, testicular support
cells also regulate Leydig cells to secrete the hormones. In
the present study, we measured the expression levels
of Leydig cell-specific antibodies 3b-HSD, through flow
cytometry. While the level of 3b-HSD with positive
expression in the Leydig cells of the experimental group
increased gradually (up to the maximum at 21 days), the
performance began to decline after 28 days. The control
group showed no positive cells. Furthermore, the levels of
testosterone in the experimental group increased with
time, while the control group did not change significantly.
Insulin-like growth factor-1 (IGF-1) can promote prolifera-
tion of Leydig cells and secretion of steroids [27]; its
blockage is characterized by the decrease in the number of
cells and a functional decline. PDGF receptor-a (PDGFRa) is
a similar type of polymer protein, which mediates receptor
signaling pathways in primitive undifferentiated mesen-
chymal cells and plays a role in promoting mitosis to
participate in the organization model and differentiation
[28]. This protein is mainly expressed on the surface of
Leydig cells and in the seminiferous tubules of peritubular
cells. At present, PDGFRa is considered to be one of the
main factors that prompt the Leydig cells to mature.
Rothschild et al. [29] reported that the function of Leydig
cell surface receptors is to stimulate the proliferation of
spermatogonial stem cells. Sriraman et al. [30] confirmed
that FSH promotes the vitality of mullerian inhibitory sub-
stance (MIS) and results in a reduced ability of Leydig cells
to synthesize testosterone. IL-1a can be evoked by
inflammation, infection, or tumor, and can produce multi-
functional cytokines [31]. Therefore, immature Leydig cells
show the ability to differentiate. In addition, Leydig cells
play a regulatory role in the secretion of glucocorticoids
[32], nickel ions (Ni2þ) [33], macrophages [34], etc. How-
ever, the exact mechanism remains unclear, and is still in
the research stage.
Taken together, in the present study, the experimental
group showed an increase in the cell volume and the cells
displayed intercellular pull mesh and an adherent growth.
The present research describes the growth of Leydig cells,
their developmental conditions, and induction of BMSC
cultivation. These findings may serve as a useful source in
solving problems like immune rejection and many such is-
sues. Our approach was to use a certain amount of cell-
inducing factors in the normal cell culture, including HMG
(LH and FSH), HCG/PDGFRa/IL-1a, and IL-1a. Leydig cellsin reaction genetic testing.
Gene
c HSD3b1d HSD3b6
.145 1.491  0.173 1.331  0.162
.145 0.323  0.032 0.351  0.042
tically significant (p < 0.05).
8 L. Hou et al.being terminal cells use a variety of cytokines and cell
surface signaling pathways for the proliferation and dif-
ferentiation in the complex microenvironment in vivo.
The purpose of this study was to simulate the microen-
vironment of a testicular established cellular model
in vitro. Meanwhile, the innovation of this study lies in the
human BMSCs being used as seed cells. The advantage of
this cellular model is that the cells are easy to collect and
culture. Furthermore, this cell model reduced the re-
cipient’s immune rejection. However, this cellular model
design has itself applicable limitations. The cellular model
achieves senescence after 21 days. Mainly manifested,
above all, the Leydig cells are steroid cells and are capable
of secretion. So the cell model will produce more cell
metabolism impurities after 21 days, which will affect the
microscopic field of view. Further to this, the cells age, lack
vitality, and show androgen decline. But at least this
approach is a step in the right direction; probably the best
answer is a synergy of various solutions.
Conclusion
On the basis of the results of this study, we conclude the
following: (1) BMSCs can be isolated and cultured in vitro;
(2) hormones induce the differentiation of Leydig cells and
establish the cellular model; and (3) testicular growth with
micro-simulation environment promotes the differentiation
of BMSCs into Leydig cells. This research shows therapeutic
potential for the clinical treatment of patients with low
androgen levels, especially for patients with complete loss
of endogenous Leydig cells.
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